Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Sur

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Medicine and Pharmacy Reports|April 9, 2019
Colorectal cancer: evolution of screening strategiesDaniel Sur, Marius Colceriu, Genel Sur, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|November 12, 2020
Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020Maria Lucia Sur, Remus Gaga, Călin Lazăr, et al.
Maedica|January 2, 2015
The relevance of inflammatory markers in metabolic syndromeGenel Sur, Emanuela Floca, Liana Kudor-Szabadi, et al.
Medicine and Pharmacy Reports|September 5, 2022
Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic reviewDaniel Sur, Andrei Havasi, Cristian Virgil Lungulescu, et al.
Journal of Personalized Medicine|May 25, 2024
Clinical Outcome of Colorectal Cancer Patients with Concomitant Hypertension: A Systematic Review and Meta-AnalysisDaniel Sur, Constantin Ionut Coroama, Alessandro Audisio, et al.
Life (Basel, Switzerland)|February 25, 2022
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint BlockadeAlecsandra Gorzo, Diana Galos, Simona Ruxandra Volovat, et al.
Journal of Personalized Medicine|January 27, 2026
Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with PanitumumabTeodor Marian Vancea, Andrada Olivia Tapirdea, Mihai Gabriel Zait, et al.
Cureus|August 1, 2022
Long Term Administration of Nivolumab for Metastatic Melanoma: A Case ReportAdela-Raluca Oprea, Arnaud Benas, Andrei Havasi, et al.
Scientific Reports|May 19, 2026
The therapeutic potential of antibody-drug conjugates in advanced colorectal cancer: a systematic review and meta-analysisDaniel Sur, Ionut-Constantin Coroama, Alecsandra Gorzo, et al.
Cancers|November 27, 2024
Survival and Treatment Outcomes in Gastric Cancer Patients with Brain Metastases: A Systematic Review and Meta-AnalysisDaniel Sur, Adina Turcu-Stiolică, Emil Moraru, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Medicine and Pharmacy Reports|April 9, 2019
Colorectal cancer: evolution of screening strategiesDaniel Sur, Marius Colceriu, Genel Sur, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|November 12, 2020
Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020Maria Lucia Sur, Remus Gaga, Călin Lazăr, et al.
Maedica|January 2, 2015
The relevance of inflammatory markers in metabolic syndromeGenel Sur, Emanuela Floca, Liana Kudor-Szabadi, et al.
Medicine and Pharmacy Reports|September 5, 2022
Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic reviewDaniel Sur, Andrei Havasi, Cristian Virgil Lungulescu, et al.
Journal of Personalized Medicine|May 25, 2024
Clinical Outcome of Colorectal Cancer Patients with Concomitant Hypertension: A Systematic Review and Meta-AnalysisDaniel Sur, Constantin Ionut Coroama, Alessandro Audisio, et al.
Life (Basel, Switzerland)|February 25, 2022
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint BlockadeAlecsandra Gorzo, Diana Galos, Simona Ruxandra Volovat, et al.
Journal of Personalized Medicine|January 27, 2026
Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with PanitumumabTeodor Marian Vancea, Andrada Olivia Tapirdea, Mihai Gabriel Zait, et al.
Cureus|August 1, 2022
Long Term Administration of Nivolumab for Metastatic Melanoma: A Case ReportAdela-Raluca Oprea, Arnaud Benas, Andrei Havasi, et al.
Scientific Reports|May 19, 2026
The therapeutic potential of antibody-drug conjugates in advanced colorectal cancer: a systematic review and meta-analysisDaniel Sur, Ionut-Constantin Coroama, Alecsandra Gorzo, et al.
Cancers|November 27, 2024
Survival and Treatment Outcomes in Gastric Cancer Patients with Brain Metastases: A Systematic Review and Meta-AnalysisDaniel Sur, Adina Turcu-Stiolică, Emil Moraru, et al.
Pageof 6